Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19

Huanyuan Luo, Yuancheng Wang, Songqiao Liu, Ruoling Chen, Tao Chen, Yi Yang, Duolao Wang, Shenghong Ju

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: ≤ 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single onset, fever, cough, peripheral capillary oxygen saturation, lymphocyte count, platelet count, albumin level, C-reactive protein (CRP) level and fibrinogen level on admission. Patients with score ≥ 41% had a dramatic increased risk of severe or critical illness [odds ratio (OR), 15.58, 95% confidence interval (CI) 3.82-63.53), intensive care unit (ICU)] admission (OR, 6.26, 95% CI 2.15-18.23), respiratory failure (OR, 19.49, 95% CI 4.55-83.40), and a prolonged hospital stay (coefficient, 2.59, 95% CI 0.46-4.72) compared to those with score ≤ 5%. CT pulmonary opacity score on admission, especially when ≥ 41%, was closely related to some clinical characteristics and was an independent predictor of disease severity, ICU admission, respiratory failure and long hospital stay in patients with COVID-19.

Original languageEnglish
Pages (from-to)153-163
Number of pages11
JournalInternal and Emergency Medicine
Volume17
Issue number1
DOIs
Publication statusPublished - 30 Jun 2021

Keywords

  • 2019-nCoV
  • Coronavirus
  • COVID-19
  • CT
  • Prognosis
  • Pulmonary opacity

Fingerprint

Dive into the research topics of 'Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19'. Together they form a unique fingerprint.

Cite this